Mr. Mazzo will serve as chief executive of AcuFocus, a company in Versant’s portfolio. He will help the firm expand its ophthalmology-related opportunities.
Versant Ventures is a venture capital firm with investments in medical devices, biopharmaceuticals and life science technologies. The firm has heavily invested in eye condition treatments.
More Articles on Ophthalmology:
Gordon-Weiss-Schanzlin Vision Institute Eye Surgeons Perform New LASIK Surgery
Bausch + Lomb Acquires Developmental Agent to Treat Dry Eye Syndrome
University of Oklahoma’s Dean McGee Eye Institute Receives $110k Grant from Research to Prevent Blindness
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
